Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone propionate + salmeterol MDI versus DPI comparator in adults with chronic asthma
2017-000735-14Phase 4Completed
- Sponsor
- Lek-AM
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fluticasone propionate and salmeterol in asthma (2 arms), sponsored by Lek-AM. Primary endpoint: Average morning peak expiratory flow. Started Oct 2017; status: completed.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2017-000735-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000735-14.